Obatoclax Mesylate (GX15-070)

Catalog No.S1057

Obatoclax Mesylate (GX15-070) is an antagonist of Bcl-2 with Ki of 0.22 μM in a cell-free assay, can assist in overcoming MCL-1 mediated resistance to apoptosis. Phase 3.

Price Stock Quantity  
USD 190 In stock
USD 170 In stock
USD 320 In stock
USD 870 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Obatoclax Mesylate (GX15-070) Chemical Structure

Obatoclax Mesylate (GX15-070) Chemical Structure
Molecular Weight: 413.49

Validation & Quality Control

9 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Obatoclax Mesylate (GX15-070) is available in the following compound libraries:

Bcl-2 Inhibitors with Unique Features

  • Pan Bcl-2 Inhibitor

    ABT-737 Bcl-xL, EC50=78.7 nM; Bcl-2, EC50=30.3 nM; Bcl-w, EC50=197.8 nM.

  • Most Potent Bcl-2 Inhibitor

    ABT-263 (Navitoclax) Bcl-xL, Ki≤ 0.5 nM; Bcl-2, Ki≤ 1 nM; Bcl-w, Ki≤ 1 nM.

  • Newest Bcl-2 Family Activator

    BAM7 Direct and selective activator of proapoptotic Bax with EC50 of 3.3 μM.

  • Classic Bcl-2 Inhibitor

    ABT-737 BH3-mimetic inhibitor, Bcl-xL, EC50=78.7 nM; Bcl-2, EC50=30.3 nM; Bcl-w, EC50=197.8 nM.

Product Information

  • Compare Bcl-2 Inhibitors
    Compare Bcl-2 Products
  • Research Area

Product Description

Biological Activity

Description Obatoclax Mesylate (GX15-070) is an antagonist of Bcl-2 with Ki of 0.22 μM in a cell-free assay, can assist in overcoming MCL-1 mediated resistance to apoptosis. Phase 3.
Targets Bcl-2 [1]
(Cell-free assay)
IC50 0.22 μM(Ki)
In vitro Obatoclax completely inhibits Bak recovery of Mcl-1 at 5 μM in SK-Mel5 cells and overcomes resistance to ABT-373-induced apoptosis conferred by Mcl-1 in KB/Bcl-2 cells. [1] Obatoclax is a BH3 mimetic which binds to a broad spectrum of Bcl-2 family members, including Bcl-2, Bcl-xL, and Mcl-1. Obatoclax uniquely displaces BH3 domains by activation of the pocket of Mcl-1 followed by a triggering of apoptosis mediated by oligomerization of Bak and release of cytochrome c. Obatoclax is sensitive to Bcl-xL in cell lines lacking it or showing low expression. It shows low cytotoxicity to Mcl-1, Bcl-2, and Bcl-xL in all the strongly-expressed cell lines. Obatoclax inhibits multiple myeloma (MM) cell lines (KMS12PE, KMS18, MY5, etc.) with IC50 values ranging from 52 to 1100 nM and the inhibition is umimpaired even in the presence of IL-6 or IGF-1, which are resistance to cytotoxic agents, at a concentration of 150 nM. Obatoclax enhances the antimyeloma activity induced by melphalan, dexamethasone, or bortezomib. [2] Obatoclax potentiates TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-mediated apoptosis by unsequestering Bak and Bim from Bcl-2/Bcl-xL or Mcl-1 proteins in PANC-1 and BxPC-3 cells. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
KARPAS-45NV3EZXNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jJbmlEPTB;MD6wNFAxOzF5IN88US=>MULTRW5ITVJ?
SK-MEL-30MlixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXSXlFKSzVyPUCuNFAxOzV3IN88US=>M3HUZXNCVkeHUh?=
NALM-6MlvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXFU49KSzVyPUCuNFAxOzV4IN88US=>NYHxOGRPW0GQR1XS
KYSE-450NYTGRlliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\OTWNKSzVyPUCuNFAxPDZ7IN88US=>NYnYc4JLW0GQR1XS
BHYMl7lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\ofWlEPTB;MD6wNFA3ODFizszNMnTHV2FPT0WU
GR-STNETEfW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkH3TWM2OD1yLkCwNFY1QCEQvF2=M3LtVnNCVkeHUh?=
786-0Mo\CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\lcopKSzVyPUCuNFAxPzd4IN88US=>MUPTRW5ITVJ?
C-33-ANG\qOHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjzZZU2UUN3ME2wMlAxODh2ODFOwG0>MmHYV2FPT0WU
BHT-101NYXjdmRYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXznT|h1UUN3ME2wMlAxOTB4IN88US=>M3Ttd3NCVkeHUh?=
EB2Mnj3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXYXoViUUN3ME2wMlAxOTF6IN88US=>MY\TRW5ITVJ?
G-361MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXeySVFPUUN3ME2wMlAxOTJ2IN88US=>MoXCV2FPT0WU
KE-37MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvDVYxKSzVyPUCuNFAyOjhizszNM{e2S3NCVkeHUh?=
MHH-PREB-1M4jkU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1XW[WlEPTB;MD6wNFE1KM7:TR?=MVvTRW5ITVJ?
MCF7NFjjR4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoW2TWM2OD1yLkCwNVU6KM7:TR?=NV:wUlJmW0GQR1XS
LOUCYMlf1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPJT2JKSzVyPUCuNFAyPzVizszNM1exdnNCVkeHUh?=
EW-7MnnOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTBwMECxO|Uh|ryPNFzlb3ZUSU6JRWK=
KYSE-510M1Gxb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkT0TWM2OD1yLkCwNlM{KM7:TR?=M{DwSHNCVkeHUh?=
SK-MEL-3M4HON2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTkTJVtUUN3ME2wMlAxOjZ2IN88US=>NUjabYF7W0GQR1XS
HAL-01Mn3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTBwMECyPVch|ryPMoPWV2FPT0WU
HCC2998M2fF[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3H3SGlEPTB;MD6wNFM{PSEQvF2=MWrTRW5ITVJ?
A375Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrnTWM2OD1yLkCwN|Uh|ryPMXPTRW5ITVJ?
MZ7-melNVnOO|BST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIC1NpJKSzVyPUCuNFA{QTlizszNNF\kdpBUSU6JRWK=
SH-4M4D0[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTBwMEC0NVch|ryPMnfaV2FPT0WU
HT-144M1rYZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mne0TWM2OD1yLkCwOFMh|ryPNEHJT4NUSU6JRWK=
KYSE-140NULYVmZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHzGOGRKSzVyPUCuNFA1OzVizszNNV\C[4FFW0GQR1XS
PSN1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2LlVGlEPTB;MD6wNFQ3PyEQvF2=M3\RS3NCVkeHUh?=
COLO-679NFOwd2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm\aTWM2OD1yLkCwOFk5KM7:TR?=MV3TRW5ITVJ?
SW620MoezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXmSlRoUUN3ME2wMlAxPTFzIN88US=>NXG0b4I{W0GQR1XS
HGC-27MnW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\C[WhuUUN3ME2wMlAxPTJ2IN88US=>Mn7JV2FPT0WU
IGROV-1M3\mPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTVTWM2OD1yLkCwOkDPxE1?NIPz[FZUSU6JRWK=
IGR-1MnfVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTBwMEC2NFEh|ryPM4jWd3NCVkeHUh?=
EW-1MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3qxUGlEPTB;MD6wNFY2OSEQvF2=M4\Hb3NCVkeHUh?=
769-PNIrZNmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV;JR|UxRTBwMEC2O|gh|ryPM2\sUHNCVkeHUh?=
HNM1y1T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTBwMEC2O|kh|ryPMoLlV2FPT0WU
SIG-M5NEnmPWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTBwMEC3NUDPxE1?MX\TRW5ITVJ?
IST-MEL1NETJWGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDP[Is4UUN3ME2wMlAxQDF6IN88US=>NYCwSXlDW0GQR1XS
ST486NHL1V|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjYTlNjUUN3ME2wMlAxQDJ3IN88US=>M1yxOHNCVkeHUh?=
ES7MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIHicmdKSzVyPUCuNFA5PDZizszNNYnpfGIzW0GQR1XS
GAKNHzWTnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnqNJpkUUN3ME2wMlAxQDR6IN88US=>MnS3V2FPT0WU
BB30-HNCM1nxUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTwPFREUUN3ME2wMlAxQDV6IN88US=>NUTqXGVFW0GQR1XS
IPC-298NUTvZVBkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\sbFBKSzVyPUCuNFA6OjdizszNM1nBOXNCVkeHUh?=
NKM-1NV[yTFVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIflW|RKSzVyPUCuNFA6PzJizszNMlHIV2FPT0WU
RKONVvKNZZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIT1NotKSzVyPUCuNFExPDRizszNMlrRV2FPT0WU
ACNMnT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4DBNGlEPTB;MD6wNVE{OSEQvF2=M3O1[nNCVkeHUh?=
SW1417NFjGOXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGf5fZFKSzVyPUCuNFEzOjVizszNM2nmOXNCVkeHUh?=
SRNULCWldXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XpcWlEPTB;MD6wNVI{PSEQvF2=NGnpe3dUSU6JRWK=
SNG-MNF61[oZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnqNWY5UUN3ME2wMlAyOzF5IN88US=>NWXLc3VOW0GQR1XS
CAL-12TMnvyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHFSXZKSzVyPUCuNFE{PDZizszNMWfTRW5ITVJ?
HSC-3NXL1cWVQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTBwMEGzOVUh|ryPMXLTRW5ITVJ?
DOHH-2MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4X5TGlEPTB;MD6wNVQyOiEQvF2=NFP6fmJUSU6JRWK=
NB69M2fQTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVGxclVFUUN3ME2wMlAyPTZ3IN88US=>M1zRc3NCVkeHUh?=
LC-2-adNUK2OXFOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{XWNWlEPTB;MD6wNVU5OSEQvF2=MmDaV2FPT0WU
RVH-421M{TDNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVPJR|UxRTBwMEG2O|Qh|ryPNGnjd|RUSU6JRWK=
TGWM4DpT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTBwMEG3N|kh|ryPNYG2d|FqW0GQR1XS
HCC1569NEPwRnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV;QNFJ1UUN3ME2wMlAyPzl5IN88US=>MXnTRW5ITVJ?
CAL-85-1MoT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTBwMEG4N|Ih|ryPNYXIUJNNW0GQR1XS
RPMI-8402NFfneYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIn4S2RKSzVyPUCuNFE5PThizszNM13lRnNCVkeHUh?=
THP-1MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1v6W2lEPTB;MD6wNVk6QCEQvF2=NFnVbYVUSU6JRWK=
ONS-76MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjHTmhFUUN3ME2wMlAzODN4IN88US=>NWPBbZRnW0GQR1XS
A2780MonDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV62b2Z4UUN3ME2wMlAzODd7IN88US=>NYL3UnkzW0GQR1XS
RPMI-2650NEXlSpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NETMUZhKSzVyPUCuNFIzQTZizszNMnzkV2FPT0WU
MEL-HOMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLFfo1kUUN3ME2wMlAzOzR6IN88US=>M3zxV3NCVkeHUh?=
MC-CARNI\lRZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIewdWhKSzVyPUCuNFI{PTZizszNNHnMOJRUSU6JRWK=
HSC-2NXvLbWw3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljUTWM2OD1yLkCyOFY3KM7:TR?=M3LHW3NCVkeHUh?=
MEL-JUSONFG1[4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHvLc2dKSzVyPUCuNFI1PzNizszNMU\TRW5ITVJ?
CAL-62MlTNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXzPW3duUUN3ME2wMlAzPjB{IN88US=>NHTseI9USU6JRWK=
DMS-273NV3jNJh4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{C2NmlEPTB;MD6wNlg1PyEQvF2=M4Xtb3NCVkeHUh?=
S-117NV\D[mNbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NETQVZhKSzVyPUCuNFI6ODZizszNNWTFcpg3W0GQR1XS
SUP-T1NH;rcJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jZPGlEPTB;MD6wNlk1QSEQvF2=MXnTRW5ITVJ?
MZ2-MELM37yfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHHTWM2OD1yLkCyPVU6KM7:TR?=MVPTRW5ITVJ?
KYSE-270Mly1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXe1Vo9iUUN3ME2wMlAzQTd4IN88US=>MmjlV2FPT0WU
CMKMkf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXTTWM2OD1yLkCzNFI{KM7:TR?=NWL5TlN2W0GQR1XS
8505CNEO0XlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NImxdI1KSzVyPUCuNFMxPCEQvF2=M1PDbHNCVkeHUh?=
NUGC-3M{DZPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NETQdolKSzVyPUCuNFMxPDhizszNMlrRV2FPT0WU
A101DMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXHk[XpoUUN3ME2wMlA{ODV3IN88US=>MmLQV2FPT0WU
G-401M1Liemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTBwMEOwPVMh|ryPNGjZdm9USU6JRWK=
OVCAR-8M1e0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVvFUo03UUN3ME2wMlA{OTB5IN88US=>NEfUOphUSU6JRWK=
IMR-5NGK1OFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2TYSmlEPTB;MD6wN|I1PCEQvF2=M32zfXNCVkeHUh?=
DoTc2-4510NYXkVHVIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkKzTWM2OD1yLkCzN|k{KM7:TR?=Ml;1V2FPT0WU
HOSNUWxV4lnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLV[oszUUN3ME2wMlA{PDd|IN88US=>NIPQbJZUSU6JRWK=
HEC-1NFLhS4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmP6TWM2OD1yLkCzOlgh|ryPMnHwV2FPT0WU
SW756MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LSeGlEPTB;MD6wN|gzOSEQvF2=NYnQXWhnW0GQR1XS
NCI-H64Mn3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXJOFduUUN3ME2wMlA{QDR{IN88US=>MWHTRW5ITVJ?
EW-16M2PXUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoS4TWM2OD1yLkCzPVA6KM7:TR?=NHLTOHRUSU6JRWK=
CAL-51M3jGVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\uNZViUUN3ME2wMlA1ODB3IN88US=>NYiyRYF1W0GQR1XS
KYSE-150M2HpeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;peWlEPTB;MD6wOFAyOSEQvF2=M4LoN3NCVkeHUh?=
SW1710MlvXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYn1U3k1UUN3ME2wMlA1ODF6IN88US=>M17k[XNCVkeHUh?=
HuP-T4NG\ybYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTBwMESxNVgh|ryPNFfDVYNUSU6JRWK=
LB373-MEL-DNE\Tbm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlLzTWM2OD1yLkC0NlMzKM7:TR?=MV;TRW5ITVJ?
EW-13M2nNOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPwZ3ZKSzVyPUCuNFQ1ODZizszNNIryUolUSU6JRWK=
HT-29M2TBW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zGfWlEPTB;MD6wOFQ6KM7:TR?=NHTudnlUSU6JRWK=
SCC-25Mn3US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV\JR|UxRTBwMES0PVQh|ryPNVqzdld1W0GQR1XS
REHM37TcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PtW2lEPTB;MD6wOFY{PSEQvF2=NUHVOo0zW0GQR1XS
L-363MlLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17NcmlEPTB;MD6wOFY4QSEQvF2=NYjjTXB5W0GQR1XS
NCI-H1770NGrpcW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzQR2RKSzVyPUCuNFQ3QTdizszNNFi5Vo9USU6JRWK=
CHL-1M1ewfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2THOGlEPTB;MD6wOFg2PyEQvF2=NUXOc3NCW0GQR1XS
ES1NVnmRmtqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXjJR|UxRTBwMES4PFUh|ryPMYjTRW5ITVJ?
SCC-15NVrQeWRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTBwMES5NFIh|ryPMl3rV2FPT0WU
MRK-nu-1MnTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmS3TWM2OD1yLkC0PVM3KM7:TR?=NHPvcW5USU6JRWK=
PF-382MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEDFbI1KSzVyPUCuNFQ6OzlizszNNHGw[lhUSU6JRWK=
COLO-680NNWHU[I1iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2L4W2lEPTB;MD6wOVA1PyEQvF2=M2fUZXNCVkeHUh?=
LK-2MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfETWM2OD1yLkC1NFY{KM7:TR?=NEPKNY5USU6JRWK=
NCI-H2342M1\J[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fte2lEPTB;MD6wOVEyPyEQvF2=NX:yNlhJW0GQR1XS
HMV-IINF62d5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELuXVdKSzVyPUCuNFUzOzlizszNNGfQXpZUSU6JRWK=
PC-14M4fNXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M123TmlEPTB;MD6wOVI2OiEQvF2=MX3TRW5ITVJ?
COLO-320-HSRMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTBwMEWyPFkh|ryPNUP1dmpWW0GQR1XS
697NYftUXZlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2nkXWlEPTB;MD6wOVMzOyEQvF2=M361VXNCVkeHUh?=
NEC8MkTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmeyTWM2OD1yLkC1OVkh|ryPNFjRU2FUSU6JRWK=
LCLC-97TM1NULBZmd[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTBwMEW1PVQh|ryPMny3V2FPT0WU
DaoyMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlrCTWM2OD1yLkC1OlE3KM7:TR?=MX7TRW5ITVJ?
ETK-1M3O2Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zEU2lEPTB;MD6wOVY4OiEQvF2=NIf3UXlUSU6JRWK=
A388NISxbIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Moj1TWM2OD1yLkC1Olk2KM7:TR?=NHv4TmdUSU6JRWK=
COLO-205NGHMTmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jkN2lEPTB;MD6wOVcyPiEQvF2=MWrTRW5ITVJ?
SK-PN-DWNX\EW5JmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTBwMEW3Nlkh|ryPMUXTRW5ITVJ?
SF268M{HmZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPpc4JnUUN3ME2wMlA2PzV4IN88US=>NUmzV49xW0GQR1XS
OCI-AML2NGLZTnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHTiZotKSzVyPUCuNFU4PzdizszNM3rHfHNCVkeHUh?=
GAMGNGrRR|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzJTWM2OD1yLkC1PEDPxE1?NVLlb2VwW0GQR1XS
BCPAPNGDQ[mlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1TYNGlEPTB;MD6wOVg6OiEQvF2=NFS0XYlUSU6JRWK=
BC-1M1e5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnwTWM2OD1yLkC2NFIzKM7:TR?=NFHYdlFUSU6JRWK=
IA-LMNXHYUYRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTBwME[wOVMh|ryPNIL0N5VUSU6JRWK=
NCI-H1299MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvSOpJKSzVyPUCuNFYyOyEQvF2=NWHmcZoxW0GQR1XS
COR-L23NEXyXVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTBwME[xN|Qh|ryPNYrmdmRMW0GQR1XS
KYSE-180MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W1XWlEPTB;MD6wOlE1OiEQvF2=MUDTRW5ITVJ?
LOXIMVIM1vKS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDIbXpKSzVyPUCuNFYyQDhizszNMmPEV2FPT0WU
BL-41NYDVcpg6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIX4WGdKSzVyPUCuNFYzOTlizszNM334cXNCVkeHUh?=
BL-70MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX63dGZmUUN3ME2wMlA3OzB{IN88US=>NUDXb4RPW0GQR1XS
NOS-1NHLOV4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH3qc4tKSzVyPUCuNFY1OTFizszNMkPUV2FPT0WU
NB13MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPITWM2OD1yLkC2OFIyKM7:TR?=MlHiV2FPT0WU
CAL-27M1zjeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\OWWRKSzVyPUCuNFY1PjRizszNM1vKNXNCVkeHUh?=
CA46M1u3R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILie41KSzVyPUCuNFY2OzdizszNMVfTRW5ITVJ?
SW962MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\tfGpmUUN3ME2wMlA3PTZ7IN88US=>Ml;NV2FPT0WU
NCI-H226M2Xk[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTBwME[2N|Ih|ryPMXjTRW5ITVJ?
KYSE-70MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnSTWM2OD1yLkC2PVQ2KM7:TR?=M3XqfXNCVkeHUh?=
DaudiNXzvRXd5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoC3TWM2OD1yLkC3NFgyKM7:TR?=NV3IcFJxW0GQR1XS
SW626NE[4dY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlnPTWM2OD1yLkC3NlA1KM7:TR?=NEKxTVFUSU6JRWK=
ESS-1NHnQOXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnrOTWM2OD1yLkC3NlQ3KM7:TR?=Mnz3V2FPT0WU
YTNUX4V4IzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPiRZNMUUN3ME2wMlA4OzR3IN88US=>Mnf0V2FPT0WU
P12-ICHIKAWANYLyPFA4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPXTWM2OD1yLkC3N|Q6KM7:TR?=MoD2V2FPT0WU
BxPC-3M4XtOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2C5TGlEPTB;MD6wO|Q2QCEQvF2=NIqyXpJUSU6JRWK=
CTV-1M4DFR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYG0Um9RUUN3ME2wMlA4PTF5IN88US=>NYfxXlJKW0GQR1XS
MLMAMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHZTWM2OD1yLkC3OVM1KM7:TR?=NFX5ZVJUSU6JRWK=
WSU-NHLNIKzRmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkD2TWM2OD1yLkC3OVU1KM7:TR?=NIPJfZBUSU6JRWK=
CTB-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLFTWM2OD1yLkC3OVg5KM7:TR?=NVTVN2RsW0GQR1XS
MMAC-SFM2LCPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTBwMEe2Olgh|ryPNXrMSolDW0GQR1XS
8-MG-BAM1rKPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LmfWlEPTB;MD6wO|gxOSEQvF2=NILGOnFUSU6JRWK=
NCI-H358Mki0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXaeoFKSzVyPUCuNFc5PzlizszNM4rJb3NCVkeHUh?=
BFTC-905NV7wZ|hDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHThPY1KSzVyPUCuNFc6ODlizszNNGLBe2dUSU6JRWK=
NCI-H727MkHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTBwMEiwOVMh|ryPNVPIV3BNW0GQR1XS
CHP-212MnTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIjUPXlKSzVyPUCuNFgxQTVizszNMmXNV2FPT0WU
HOP-62M4T2O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3z1SWlEPTB;MD6wPFI1PSEQvF2=NV\TeItTW0GQR1XS
CESSMmrhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7Zb|dKSzVyPUCuNFgzPjlizszNNYOy[owxW0GQR1XS
HuCCT1NXnTVIpqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;WTWM2OD1yLkC4N|M{KM7:TR?=MkmzV2FPT0WU
DELM3Pj[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PnbWlEPTB;MD6wPFM1PyEQvF2=NIW1VI9USU6JRWK=
5637MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLQSnRKSzVyPUCuNFg{PjdizszNNGCzVZNUSU6JRWK=
RS4-11M{fLXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\R[mpKSzVyPUCuNFg1QTdizszNNVLJOnhEW0GQR1XS
KURAMOCHIM{[2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NET0SHlKSzVyPUCuNFg2ODlizszNNH20VZFUSU6JRWK=
A427MmDyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIPCPWFKSzVyPUCuNFg2OTJizszNM{nW[nNCVkeHUh?=
A3-KAWMo\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTBwMEi1OlYh|ryPM1H5WnNCVkeHUh?=
LS-123M1jkUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX73[IZNUUN3ME2wMlA5PzF7IN88US=>M4nkXHNCVkeHUh?=
LoVoNV;VdnZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTZTWM2OD1yLkC4O|Ih|ryPNGf4PGRUSU6JRWK=
PA-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mo\UTWM2OD1yLkC4O|Y6KM7:TR?=NFPZOZNUSU6JRWK=
CP50-MEL-BNW\BeJo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXUNmJpUUN3ME2wMlA5Pzl|IN88US=>Mof6V2FPT0WU
A431NFPoS45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvyeIFLUUN3ME2wMlA5QDBzIN88US=>MmjyV2FPT0WU
HCT-116NFP6ZmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPITWM2OD1yLkC4PFAzKM7:TR?=M3TCR3NCVkeHUh?=
A4-FukMlnaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEL4cG9KSzVyPUCuNFg6PDdizszNMn7WV2FPT0WU
RPMI-6666MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTBwMEi5Olch|ryPMWDTRW5ITVJ?
Calu-6MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\kOZZmUUN3ME2wMlA6ODJ7IN88US=>M4DlcXNCVkeHUh?=
KMOE-2M1LaPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTBwMEmwN|kh|ryPMnXLV2FPT0WU
A704Mn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1XZZWlEPTB;MD6wPVE2KM7:TR?=Ml\oV2FPT0WU
HO-1-N-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGjUVZFKSzVyPUCuNFkzPDlizszNMmLUV2FPT0WU
NCI-H2122MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7Jd|BNUUN3ME2wMlA6Ozd6IN88US=>MmXpV2FPT0WU
U-698-MMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTBwMEm0NFkh|ryPNXzXb2ZpW0GQR1XS
IST-SL2MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPiTId1UUN3ME2wMlA6PDZ6IN88US=>NF7LZ|RUSU6JRWK=
TE-10NIjLd|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLUZVB7UUN3ME2wMlA6PTh2IN88US=>MWTTRW5ITVJ?
PANC-03-27MofWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPvfZR3UUN3ME2wMlA6PjdzIN88US=>M{LWdHNCVkeHUh?=
KYSE-410NFHMc41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoS4TWM2OD1yLkC5O|k4KM7:TR?=NYTCVZB1W0GQR1XS
TE-8MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVz2PHhmUUN3ME2wMlA6QDh3IN88US=>MYrTRW5ITVJ?
MN-60MnLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4DDTmlEPTB;MD6wPVg6PyEQvF2=M2jLV3NCVkeHUh?=
NCI-H460MoXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV\JR|UxRTBwMUCwPUDPxE1?NVLGOGFJW0GQR1XS
LB771-HNCNEK5OFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDxWI5KSzVyPUCuNVAzPTVizszNMnexV2FPT0WU
ES4M{XaTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3We5BIUUN3ME2wMlExOjZ2IN88US=>M4WzXHNCVkeHUh?=
HUTU-80NWraZpVTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkD0TWM2OD1yLkGwN|Y2KM7:TR?=MXjTRW5ITVJ?
647-VNGmwNZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHzrN2pKSzVyPUCuNVA1ODhizszNNUnvfXM3W0GQR1XS
HTC-C3MkPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEC0U4ZKSzVyPUCuNVA1OzJizszNMU\TRW5ITVJ?
NTERA-S-cl-D1MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fQNGlEPTB;MD6xNFQ1QCEQvF2=M{fa[3NCVkeHUh?=
A2058MmO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7qSlBmUUN3ME2wMlExPjV3IN88US=>MkHCV2FPT0WU
MZ1-PCMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITXfo5KSzVyPUCuNVA5OyEQvF2=M1jHbHNCVkeHUh?=
J82NF7OVY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFn0bVBKSzVyPUCuNVA5QDRizszNMX7TRW5ITVJ?
ARH-77M3jESGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml:yTWM2OD1yLkGxJO69VQ>?NHrSenlUSU6JRWK=
Ca9-22NGmwc25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVXVNXhTUUN3ME2wMlEyOTJ6IN88US=>NFi3VmNUSU6JRWK=
NCI-H1648MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHSTWM2OD1yLkGxNlg3KM7:TR?=NXe3UIhHW0GQR1XS
MC116MoXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvyTZdKSzVyPUCuNVE{OzdizszNNFnHdGdUSU6JRWK=
EoL-1-cellMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMUG0Olch|ryPMVvTRW5ITVJ?
PANC-10-05M3:2O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTBwMUG0PVEh|ryPMo\LV2FPT0WU
SF539NHHXbWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjObHB3UUN3ME2wMlEyPjF4IN88US=>MonLV2FPT0WU
ES8MmnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3iwXWlEPTB;MD6xNVY{OyEQvF2=M1jGVHNCVkeHUh?=
NCI-H810NWPjfmo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGGyXnJKSzVyPUCuNVE3PjRizszNNWLiTppIW0GQR1XS
J-RT3-T3-5NYLoc|d4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPvTWM2OD1yLkGxO|Uh|ryPNV;UdmpyW0GQR1XS
NYNWPV[It{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwMUG4NVch|ryPMUPTRW5ITVJ?
NCI-SNU-1M3vUV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7xTWM2OD1yLkGyNVQ5KM7:TR?=MmLQV2FPT0WU
EFM-19M1fv[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTvdo5KSzVyPUCuNVI{PzRizszNNWXidJh6W0GQR1XS
HCC1806MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWL5WphpUUN3ME2wMlEzOzh|IN88US=>NGrhPIhUSU6JRWK=
HCE-TMmT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml6wTWM2OD1yLkGyOVMyKM7:TR?=MUHTRW5ITVJ?
HT-1376MnHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX7EW2dSUUN3ME2wMlEzPjZ6IN88US=>MYXTRW5ITVJ?
BE-13Mn\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTxTWM2OD1yLkGyPFY3KM7:TR?=MWfTRW5ITVJ?
NCI-H520M1zSfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPMTWM2OD1yLkGyPFY4KM7:TR?=NUHGSGdjW0GQR1XS
SK-MES-1MojiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTBwMUK5NVMh|ryPNH\tO3dUSU6JRWK=
SNU-423MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTBwMUK5NVQh|ryPMkTwV2FPT0WU
Ramos-2G6-4C10MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvRdIdKSzVyPUCuNVI6OTZizszNMmjqV2FPT0WU
EW-18NXfGRo0zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTBwMUOwNlYh|ryPMWHTRW5ITVJ?
NCI-H2087NH;pPJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1i0OGlEPTB;MD6xN|AzPyEQvF2=M3S0XHNCVkeHUh?=
COLO-792Mn;xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkTkTWM2OD1yLkGzNVY2KM7:TR?=NEPoXYdUSU6JRWK=
QIMR-WILNWjxRpJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jFNGlEPTB;MD6xN|IzOyEQvF2=NImxW2FUSU6JRWK=
ACHNMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2T3TGlEPTB;MD6xN|I1PyEQvF2=MlPVV2FPT0WU
RPMI-8866NGHjSlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\JTWM2OD1yLkGzNlYyKM7:TR?=NXe2S4RQW0GQR1XS
SK-LU-1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYfybllnUUN3ME2wMlE{PDR7IN88US=>NGG5fHVUSU6JRWK=
SK-UT-1M1nyU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nLcmlEPTB;MD6xN|YzQCEQvF2=M1XIUnNCVkeHUh?=
MFE-296M4fCdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;CTWM2OD1yLkGzPFY1KM7:TR?=M3XDR3NCVkeHUh?=
RDMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3m5TWlEPTB;MD6xN|k6PyEQvF2=NXOzeoNEW0GQR1XS
LS-411NM{D6Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTBwMUSyPVUh|ryPM4rNe3NCVkeHUh?=
NCI-H747NXryNHJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPWdnloUUN3ME2wMlE1OyEQvF2=MXvTRW5ITVJ?
ES6NVjRVlNOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVvJR|UxRTBwMUSzOkDPxE1?NWnXV2d7W0GQR1XS
TE-1NFjrOWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\wS5pKUUN3ME2wMlE1PDB5IN88US=>Ml7PV2FPT0WU
SJSA-1NYrsOVk4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\ydmlEPTB;MD6xOFcxPyEQvF2=NX7uOJVNW0GQR1XS
NCI-H1355MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTBwMUWyPVMh|ryPNF;xOVNUSU6JRWK=
HELM3TQb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rz[WlEPTB;MD6xOVQ1PyEQvF2=NWm1PFV4W0GQR1XS
639-VMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mmq5TWM2OD1yLkG1OVk3KM7:TR?=NILKPI1USU6JRWK=
AN3-CAM1riZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;QVIxKSzVyPUCuNVU3OzlizszNM3[1OHNCVkeHUh?=
SK-MEL-2M{fkOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2HOTWlEPTB;MD6xOVY3QCEQvF2=NIT4N3hUSU6JRWK=
SW872NVv2T5FZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvoXZhKSzVyPUCuNVYxPDJizszNMn3QV2FPT0WU
DU-4475MmjWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\4TWM2OD1yLkG2NVYzKM7:TR?=NIHVSZpUSU6JRWK=
YKG-1MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTBwMU[yO|Mh|ryPMkP2V2FPT0WU
GT3TKBM{fUVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1PU[2lEPTB;MD6xOlI5OyEQvF2=M3jCUXNCVkeHUh?=
GB-1M3PhXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTBwMU[0NlQh|ryPM3uzZXNCVkeHUh?=
KARPAS-422M3W5Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;1fGlEPTB;MD6xOlU4PCEQvF2=MoTjV2FPT0WU
ATN-1MnXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVSxdZVUUUN3ME2wMlE3PjV4IN88US=>M2XrbXNCVkeHUh?=
HLEMoXLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{fR[2lEPTB;MD6xOlg4PyEQvF2=NWnCVnBvW0GQR1XS
D-542MGM13ENGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\3bJJ4UUN3ME2wMlE3QTh4IN88US=>NWH6d5hGW0GQR1XS
EB-3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPTTWM2OD1yLkG3N|Eh|ryPNVjqbmY6W0GQR1XS
HCC1143NVHTT5gxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPQTWM2OD1yLkG3N|k3KM7:TR?=NWHzPZRvW0GQR1XS
DJM-1M4XlXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfjTWM2OD1yLkG3OFUyKM7:TR?=MWfTRW5ITVJ?
BT-474NGDBNWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1v4NGlEPTB;MD6xO|Q5QSEQvF2=MYrTRW5ITVJ?
BB65-RCCNXvK[GdHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXn0d2xQUUN3ME2wMlE4PTR3IN88US=>M1LSd3NCVkeHUh?=
NCI-H292NVT3d206T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1\1[mlEPTB;MD6xO|YxOSEQvF2=M2XETXNCVkeHUh?=
MKN28MnjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIX0[|FKSzVyPUCuNVc3PTNizszNNFj5dYtUSU6JRWK=
TK10NWDNfJE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHKTWM2OD1yLkG3O|AzKM7:TR?=MX;TRW5ITVJ?
TYK-nuMnXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlz2TWM2OD1yLkG3PVQ6KM7:TR?=NXrQRnE{W0GQR1XS
8305CMkP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;iSWlEPTB;MD6xO|k4OSEQvF2=Mn3sV2FPT0WU
MV-4-11M1XmcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXzTWM2OD1yLkG3PVc4KM7:TR?=NIGycIpUSU6JRWK=
NCI-H522NVrRTXBMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jBVWlEPTB;MD6xPFA6PCEQvF2=MoroV2FPT0WU
Hs-578-TM4rPfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnyTWM2OD1yLkG4NlkzKM7:TR?=Mn3SV2FPT0WU
LCLC-103HM4nLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHW3ZYpKSzVyPUCuNVg2OjdizszNNWi1RpZCW0GQR1XS
MHH-ES-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLGblZYUUN3ME2wMlE5PjJ7IN88US=>M3X6b3NCVkeHUh?=
NCI-H441NGficmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjQTWM2OD1yLkG5NVQ5KM7:TR?=MYjTRW5ITVJ?
AM-38M1;rbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPGPIhKSzVyPUCuNVkzOjVizszNM4LXT3NCVkeHUh?=
SW1783NYjhdVBqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\yTWM2OD1yLkG5N|A2KM7:TR?=NWHNfZZKW0GQR1XS
SK-HEP-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlHTTWM2OD1yLkG5OlM4KM7:TR?=NF\vPWpUSU6JRWK=
OAW-28NVr4emk4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTBwMkCxO|gh|ryPNYjnNlZkW0GQR1XS
TE-15NGqxT3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NU\nZopCUUN3ME2wMlIxOjV{IN88US=>MVXTRW5ITVJ?
HCE-4NX\kWHFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPjTWM2OD1yLkKwNlg1KM7:TR?=NHSwN5NUSU6JRWK=
JiyoyeP-2003NXzqemRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{P3cGlEPTB;MD6yNFM{PiEQvF2=MnfKV2FPT0WU
OVCAR-4MmToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXtTWM2OD1yLkKwOlI5KM7:TR?=NIrBdHhUSU6JRWK=
SNU-449NFixTI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHq4bHpKSzVyPUCuNlA4QTdizszNMl73V2FPT0WU
SBC-5NIWyRVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFLycYNKSzVyPUCuNlEzOTVizszNMX\TRW5ITVJ?
T84MojXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4rkcmlEPTB;MD6yNVI1QCEQvF2=MUfTRW5ITVJ?
LP-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MluxTWM2OD1yLkKxN|AzKM7:TR?=NIThSZJUSU6JRWK=
MG-63NHjNb4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTBwMkGzPFIh|ryPMXvTRW5ITVJ?
OAW-42MknuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTBwMkG0O|gh|ryPNIrpZWVUSU6JRWK=
L-540M{nS[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\rc2ZyUUN3ME2wMlIyPTl6IN88US=>MnrpV2FPT0WU
RH-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPFVFBXUUN3ME2wMlIzOjR{IN88US=>NF32ellUSU6JRWK=
HCT-15NV7w[4lsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3PCXmlEPTB;MD6yNlQ5PCEQvF2=NUW4SGc{W0GQR1XS
OCUB-MNXrWcGpXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTBwMkK0PFgh|ryPNUTvWINnW0GQR1XS
GP5dMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTBwMkK1Nlgh|ryPNX\0Vm4yW0GQR1XS
NCI-H2030NX[2VWJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTBwMkK3N|Qh|ryPMYTTRW5ITVJ?
ML-2NHvJflhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHPF[3VKSzVyPUCuNlI5QDlizszNMlfhV2FPT0WU
CAL-39MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXrOXRnUUN3ME2wMlIzQTN4IN88US=>NI\udHpUSU6JRWK=
MIA-PaCa-2MnnNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{TmWWlEPTB;MD6yN|I5PyEQvF2=NHKyfI9USU6JRWK=
TE-9NGLoRYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rSeWlEPTB;MD6yN|MzKM7:TR?=NIPnbpdUSU6JRWK=
LB2518-MELMmfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1XqWmlEPTB;MD6yN|M4OiEQvF2=M4nWNHNCVkeHUh?=
DBNH;HWnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTBwMkO0N|gh|ryPMWPTRW5ITVJ?
NCI-H596M2nrNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPseo1iUUN3ME2wMlI{PTdzIN88US=>Mn3NV2FPT0WU
SW1990NVntOXI{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLJTZdKUUN3ME2wMlI{QTR4IN88US=>NETWcIVUSU6JRWK=
P30-OHKMonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\oNoJKSzVyPUCuNlQxPSEQvF2=NV3sNJQ2W0GQR1XS
ALL-POMlPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGLWeo5KSzVyPUCuNlQyPjlizszNMXjTRW5ITVJ?
Saos-2NV6xem9ZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrSTWM2OD1yLkK0OVcyKM7:TR?=NX3ZcJl[W0GQR1XS
MFH-inoM3rXS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;rd3dKSzVyPUCuNlQ3QTJizszNMmHSV2FPT0WU
OE33MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF3aNI5KSzVyPUCuNlUyOSEQvF2=NHPnNYdUSU6JRWK=
Calu-3NHO3WphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFiwbWVKSzVyPUCuNlUzQTdizszNNUTTSYNYW0GQR1XS
HTM{jqRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvOTWM2OD1yLkK1OlIyKM7:TR?=NUnvOlFQW0GQR1XS
LXF-289NFnSUmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzWNlRrUUN3ME2wMlI2QTh2IN88US=>MlS5V2FPT0WU
KGNNVrpZ2V7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTXfmRKSzVyPUCuNlYxQDlizszNNGTFblBUSU6JRWK=
NCI-H1417MoC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWT2clZYUUN3ME2wMlI3PTJ2IN88US=>M1e1XnNCVkeHUh?=
SF126MofLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7m[2pKSzVyPUCuNlc{ODJizszNMVrTRW5ITVJ?
SASNWWwPHN[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjVOZpzUUN3ME2wMlI4OzB6IN88US=>NEjjRpZUSU6JRWK=
22RV1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;wZXlKSzVyPUCuNlc{PzhizszNNV\STm1UW0GQR1XS
GI-1NWXkZYdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHzUpZTUUN3ME2wMlI4PDh5IN88US=>M2i5dHNCVkeHUh?=
ES3M1rkcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGO1T5JKSzVyPUCuNlc4PjNizszNNYfZbJRrW0GQR1XS
NB1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGjPUmdKSzVyPUCuNlc5PzZizszNMof3V2FPT0WU
NCI-H650Mlm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXHPPXZjUUN3ME2wMlI5OzB{IN88US=>NFj5NnNUSU6JRWK=
IST-MES1NXm1U5ltT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHLcGsyUUN3ME2wMlI5PTV2IN88US=>NWDLW5NkW0GQR1XS
UM-UC-3MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTBwMkmxOEDPxE1?NE\Ub5NUSU6JRWK=
CAL-120NVLk[Hl1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4e4TmlEPTB;MD6yPVY{OSEQvF2=MWPTRW5ITVJ?
UACC-62MnjjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXG1cHVGUUN3ME2wMlMxOjRzIN88US=>MYDTRW5ITVJ?
TE-11NGD5cnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFn4SIhKSzVyPUCuN|AzPDlizszNM{W0bnNCVkeHUh?=
MKN1MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTBwM{CzOkDPxE1?NE\JOmtUSU6JRWK=
KS-1MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPGXXQyUUN3ME2wMlMxPTJ4IN88US=>NUHZSINlW0GQR1XS
GCIYMo[xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVTWWpdmUUN3ME2wMlMyODB{IN88US=>MUDTRW5ITVJ?
OVCAR-5M2\mUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:wWXhLUUN3ME2wMlMyOTB4IN88US=>MoPGV2FPT0WU
U-266NH;BcHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFLE[pFKSzVyPUCuN|EyPDdizszNMUTTRW5ITVJ?
Calu-1NIWye3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTBwM{GyPFkh|ryPNUTWcppkW0GQR1XS
SK-LMS-1NEjJRplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTBwM{G0Nlkh|ryPM4qzcXNCVkeHUh?=
COLO-741M2H4VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTBwM{G2NVQh|ryPNGDufY9USU6JRWK=
RPMI-8226M4XZSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3XEW2lEPTB;MD6zNVY1OSEQvF2=NWDyXZdYW0GQR1XS
KM12NGnSTJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DVSmlEPTB;MD6zNVg{KM7:TR?=NHTmOXhUSU6JRWK=
NMC-G1NEmwN2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrtd5ZsUUN3ME2wMlMyQDZizszNM{DubnNCVkeHUh?=
SJRH30Mn31S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTBwM{KwOVIh|ryPMVjTRW5ITVJ?
COR-L105NFXHSYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjaT2lKSzVyPUCuN|IzOThizszNNIrocnBUSU6JRWK=
IM-9NXfZfGp6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHMVYhnUUN3ME2wMlM{ODJzIN88US=>M3Xyc3NCVkeHUh?=
TE-12M4rKfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLydpVbUUN3ME2wMlM{OzF5IN88US=>MonXV2FPT0WU
KG-1NEW5dXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4m5dGlEPTB;MD6zN|Q{OiEQvF2=MkDaV2FPT0WU
U251NUm0eHV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTBwM{O0OVYh|ryPNW\yU4F2W0GQR1XS
EFO-27MlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;5O2lEPTB;MD6zN|k2OSEQvF2=NHrDeXBUSU6JRWK=
EW-24MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;QOndyUUN3ME2wMlM{QTh2IN88US=>M2TicXNCVkeHUh?=
SF295MnnLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3T0fGlEPTB;MD6zN|k6QSEQvF2=M1qybXNCVkeHUh?=
MC-IXCMkOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3izemlEPTB;MD6zOFUh|ryPM1;CSnNCVkeHUh?=
NCI-H2405MoH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTZNZFKSzVyPUCuN|Q4OzJizszNNHza[FFUSU6JRWK=
NCI-H2009NH2xOo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFrNfnNKSzVyPUCuN|Q4OzlizszNNFTSdndUSU6JRWK=
LB1047-RCCNXX1Z21mT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NITs[IxKSzVyPUCuN|U5OTVizszNNIXYeY5USU6JRWK=
KNS-81-FDNUHTTYVPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\1TWM2OD1yLkO2OlY4KM7:TR?=M2jBV3NCVkeHUh?=
HOP-92NEnIV4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYWxcHFWUUN3ME2wMlM3QDNizszNNYjUXoppW0GQR1XS
L-428MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLhTWM2OD1yLkO3NFE3KM7:TR?=NWSzWIhSW0GQR1XS
C3AMkHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIryfmpKSzVyPUCuN|c{PzlizszNM33WWHNCVkeHUh?=
NCI-H1792MmTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkH0TWM2OD1yLkO3OlU2KM7:TR?=M165ZXNCVkeHUh?=
HuH-7MnnlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDJ[4lKSzVyPUCuN|c6OSEQvF2=NYX0UJdUW0GQR1XS
AGSMnjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTBwM{i2N|gh|ryPMYnTRW5ITVJ?
HT-1197NYPuW3E1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2G3WmlEPTB;MD6zPVQ3KM7:TR?=NUTFbHNNW0GQR1XS
CGTH-W-1M2DwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MomzTWM2OD1yLkO5PVE{KM7:TR?=MXvTRW5ITVJ?
KNS-42MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzWTWM2OD1yLkSwNFQ2KM7:TR?=MoLQV2FPT0WU
HuO-3N1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTBwNECwOVUh|ryPM3z0fnNCVkeHUh?=
VMRC-RCZMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHju[lJKSzVyPUCuOFA{ODNizszNM1HsdHNCVkeHUh?=
SW954NVn1fWE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NILC[WtKSzVyPUCuOFA{OzVizszNM2D2UHNCVkeHUh?=
MES-SAMn\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\M[WlEPTB;MD60NFUxPSEQvF2=M2jHO3NCVkeHUh?=
Ca-SkiNIexPFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXPJR|UxRTBwNEC1NlQh|ryPMl6yV2FPT0WU
SW13M4ftTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTBwNEC2NlYh|ryPM4P5SXNCVkeHUh?=
NCI-H1437M1jRWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEHTVYtKSzVyPUCuOFA5ODVizszNMXfTRW5ITVJ?
U-118-MGNXHqTmlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTBwNEC5NFQh|ryPMnjBV2FPT0WU
NCI-H1734NFLRfZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\QdGlEPTB;MD60NlAyOyEQvF2=MnHoV2FPT0WU
HDLM-2NUTBRo8yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDZTWM2OD1yLkSyNFM{KM7:TR?=NGTO[|ZUSU6JRWK=
AU565NWP3NVd7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHvTnlIUUN3ME2wMlQzPDZ6IN88US=>NX7lephLW0GQR1XS
FADUNGHqfJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nLRmlEPTB;MD60NlY1QSEQvF2=MYLTRW5ITVJ?
OS-RC-2NYfEZYpNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13pbGlEPTB;MD60N|A5OyEQvF2=NWLSVYc2W0GQR1XS
CAMA-1NYnONXE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkfSTWM2OD1yLkSzOlI3KM7:TR?=NHnMWY9USU6JRWK=
MONO-MAC-6NVjwc5RPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTBwNEO4OFkh|ryPM2Dt[nNCVkeHUh?=
LB831-BLCMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknHTWM2OD1yLkS0N|cyKM7:TR?=NWfmeolNW0GQR1XS
SW982NHi0O2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTBwNES1Nlgh|ryPNGT0eYFUSU6JRWK=
SCC-3NXHQdmlST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHLYfW9KSzVyPUCuOFQ2PzlizszNNHLGUotUSU6JRWK=
C32NI\wTnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mni3TWM2OD1yLkS1NlI6KM7:TR?=NEDXUHBUSU6JRWK=
BFTC-909MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjaTWhKSzVyPUCuOFUzQTlizszNM4DrVHNCVkeHUh?=
MEG-01NH75[ZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVztcYRyUUN3ME2wMlQ2Ozd|IN88US=>NHG5W4lUSU6JRWK=
M14NXX3b|FGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTBwNEW5O|kh|ryPMVnTRW5ITVJ?
MPP-89NXfWcGtMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH21dIhKSzVyPUCuOFYzPTZizszNNYPyOXBzW0GQR1XS
HCC1937MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrucFdKSzVyPUCuOFY{QDRizszNNELRXYtUSU6JRWK=
SW837M1f1dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTpZ3hLUUN3ME2wMlQ3PzJ{IN88US=>MmW5V2FPT0WU
DU-145NVPtXIdQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGnwdYxKSzVyPUCuOFY4OjlizszNM37tZnNCVkeHUh?=
LB996-RCCNIHtb2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjxO4lKSzVyPUCuOFcxPTRizszNNIWxcZpUSU6JRWK=
C8166M2nobWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnhTWM2OD1yLkS3OEDPxE1?NWHqUFJEW0GQR1XS
MOLT-4M3XxbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2G2bmlEPTB;MD60O|c{PCEQvF2=NYDnZ3dNW0GQR1XS
DMS-53MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTBwNEe4NFkh|ryPNEXhV|RUSU6JRWK=
TE-5MlT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrwR5JKSzVyPUCuOFg{ODVizszNMlfLV2FPT0WU
KYSE-520M3qyWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn70TWM2OD1yLkS4N|Q{KM7:TR?=M3fMPXNCVkeHUh?=
Detroit562NWXpR25FT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFjq[HRKSzVyPUCuOFg5PiEQvF2=MWPTRW5ITVJ?
SIMANUTDNmRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRTBwNEm0NVch|ryPM{jvZ3NCVkeHUh?=
NCI-H1651NEPXXlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmLPTWM2OD1yLkS5Olch|ryPM2TwTHNCVkeHUh?=
HCC1599MlPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1:xTmlEPTB;MD60PVk2PSEQvF2=NIHHUWdUSU6JRWK=
ABC-1NFv2NFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLNTWM2OD1yLkWwOFk3KM7:TR?=NIm3R29USU6JRWK=
CAL-33MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTMUo5DUUN3ME2wMlUxQDR2IN88US=>NEXtRZBUSU6JRWK=
OPM-2MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3[zZ2lEPTB;MD61NFk{PyEQvF2=M4jN[3NCVkeHUh?=
RPMI-7951MlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGrieYhKSzVyPUCuOVA6PTdizszNM3vD[3NCVkeHUh?=
HT-1080NVnXSYw{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDPXZFKSzVyPUCuOVEyOTlizszNM33nd3NCVkeHUh?=
LC4-1Mo\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHKwOI9KSzVyPUCuOVE1ODNizszNMWfTRW5ITVJ?
OVCAR-3NWTnbYEyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPVNIdKSzVyPUCuOVE2PyEQvF2=M3u0WHNCVkeHUh?=
CAPAN-1M3rhbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1n4dmlEPTB;MD61NlI5QCEQvF2=NUXjSGMzW0GQR1XS
SK-OV-3NEnBTGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjvWYFKSzVyPUCuOVI1OzRizszNMYnTRW5ITVJ?
HuP-T3MnLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHtTWM2OD1yLkWyPFI4KM7:TR?=MmLSV2FPT0WU
NCI-H838MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnK4TWM2OD1yLkWyPFQ6KM7:TR?=M37FTXNCVkeHUh?=
K5NVj3WYYzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\DNGNKSzVyPUCuOVMzODFizszNMY\TRW5ITVJ?
CAL-72NWnQVGs3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTBwNUOzPFch|ryPMoXmV2FPT0WU
NH-12NVS1fW1GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY[1fmtrUUN3ME2wMlU{QTV7IN88US=>NHLT[ZJUSU6JRWK=
SNB75Ml3GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2LrRmlEPTB;MD61OVc{KM7:TR?=MorQV2FPT0WU
BPH-1NI[4XIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYTx[Hd7UUN3ME2wMlU3OzR2IN88US=>M{K0d3NCVkeHUh?=
NOMO-1NVrMbFFkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XjZ2lEPTB;MD61OlM4OiEQvF2=M1TB[HNCVkeHUh?=
G-402NHi2WFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlj2TWM2OD1yLkW2OFk6KM7:TR?=NGnoUotUSU6JRWK=
NCI-H2052M2e3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LVbWlEPTB;MD61Olc1OSEQvF2=MkXFV2FPT0WU
RCM-1NUjCOGFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTBwNUexOlYh|ryPMY\TRW5ITVJ?
COR-L279M17JW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPCTWM2OD1yLkW3NVg2KM7:TR?=M4LkWXNCVkeHUh?=
A253MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37EemlEPTB;MD61O|UzPSEQvF2=NGizZVBUSU6JRWK=
SK-MM-2NUiwNmxrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LDT2lEPTB;MD61O|Y4QSEQvF2=MUjTRW5ITVJ?
NCI-H1703NX34VllWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwNUm0Nlch|ryPM{\DOXNCVkeHUh?=
UACC-257MojxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPQZ|hKSzVyPUCuOVk1QDdizszNNYHMOoFzW0GQR1XS
KALS-1NYLqO493T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFHJeZFKSzVyPUCuOlAxOTFizszNM4HOVnNCVkeHUh?=
ES5Mle4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTBwNkC0PEDPxE1?NHXBdGtUSU6JRWK=
MHH-CALL-2NUO3d5Y5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTBwNkC4PFgh|ryPM{i5N3NCVkeHUh?=
ChaGo-K-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUflPWpQUUN3ME2wMlYyOjJ7IN88US=>NH:2N3hUSU6JRWK=
TGBC1TKBMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfqTWM2OD1yLk[xPVgh|ryPM16yN3NCVkeHUh?=
KU-19-19NWPwb3VuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTBwNkS1PFYh|ryPNULINIRmW0GQR1XS
COLO-684M1HzU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkL5TWM2OD1yLk[1OlEyKM7:TR?=NVzWfmNQW0GQR1XS
LS-1034M2GxdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV;FPFJrUUN3ME2wMlY2QDF7IN88US=>NHfydpFUSU6JRWK=
RT-112Mnq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXLaS|YyUUN3ME2wMlY3PTh5IN88US=>NI\3N5hUSU6JRWK=
Capan-2MmrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTBwNk[2NlIh|ryPNYLudldkW0GQR1XS
HSC-4NGC2NFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NU[xdG1WUUN3ME2wMlY3Pjl6IN88US=>Mnu1V2FPT0WU
COLO-824NUHwUYY5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;zelVKSzVyPUCuOlc5OjNizszNNUXpVFY4W0GQR1XS
NCI-H2170NFnI[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7nTWM2OD1yLk[4NlU5KM7:TR?=NETZVHdUSU6JRWK=
GDM-1NIfHTWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDnTFlKSzVyPUCuOlg1QTRizszNM1zEV3NCVkeHUh?=
KP-4NVPlWWd3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTBwNkm1O|Mh|ryPNVfrSWxRW0GQR1XS
VA-ES-BJMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\aXGU4UUN3ME2wMlY6QTh4IN88US=>NWLFNmFXW0GQR1XS
KM-H2M2jZZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDLTYNKSzVyPUCuO|AxQTFizszNM2L4VHNCVkeHUh?=
HHMl3kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTBwN{C2OlIh|ryPNFHHWYJUSU6JRWK=
DK-MGNFracopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jZVWlEPTB;MD63NVAyPiEQvF2=MVPTRW5ITVJ?
VM-CUB-1NHzOW4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPCb2JKSzVyPUCuO|EzPTlizszNNVTaU2pbW0GQR1XS
COLO-829NWfpdFFMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnzRTWM2OD1yLkexPVg2KM7:TR?=MoHvV2FPT0WU
OMC-1MlXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7qW2VKSzVyPUCuO|IyODRizszNNYfYVWw5W0GQR1XS
NB12NFqwUplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjLUI02UUN3ME2wMlczPTB2IN88US=>Mn;zV2FPT0WU
NCI-H28M3rG[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwN{SwPFMh|ryPM{DhPHNCVkeHUh?=
A673MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwN{WxO|ch|ryPMU\TRW5ITVJ?
LB2241-RCCM{nDe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPF[GZKSzVyPUCuO|YxQDdizszNMVHTRW5ITVJ?
CCRF-CEMNV;FS2xuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGS4VJBKSzVyPUCuO|cxPTJizszNNIHqXldUSU6JRWK=
NCI-H510ANWLXb2RkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r4dmlEPTB;MD63O|E5PiEQvF2=MYLTRW5ITVJ?
SW48NELseHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\nWWlEPTB;MD63O|M{OyEQvF2=MV7TRW5ITVJ?
NCI-H2081M1vXWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Moj2TWM2OD1yLke4NVQ4KM7:TR?=NYjFeVk1W0GQR1XS
RMG-INHvCfopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\MSWNbUUN3ME2wMlc5OjF{IN88US=>NIjyZ2NUSU6JRWK=
LU-99AM4npWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPOdFNKSzVyPUCuO|g1OTNizszNNG\TTnhUSU6JRWK=
KP-N-YSNV[1c5VqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7qUpBKSzVyPUCuO|g6OjFizszNMYDTRW5ITVJ?
MDA-MB-231MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{noe2lEPTB;MD64NFE{OSEQvF2=MUfTRW5ITVJ?
U031MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjNXWVnUUN3ME2wMlgyPDJ|IN88US=>MmLvV2FPT0WU
EVSA-TMoL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTjcHVKSzVyPUCuPFE3PzJizszNNHHMXJNUSU6JRWK=
MDA-MB-157NEjtcpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTBwOEKyO|Eh|ryPMlfZV2FPT0WU
EHEBMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2rUfGlEPTB;MD64NlI4PiEQvF2=NVT6NHV4W0GQR1XS
KINGS-1NXrESFlMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjITWM2OD1yLkiyOVU2KM7:TR?=NXHjbXhkW0GQR1XS
23132-87MonXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEGzV5BKSzVyPUCuPFI5PDNizszNNV76ZYJFW0GQR1XS
EFO-21NU\RUoJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4D2OWlEPTB;MD64OFA5QSEQvF2=Mn7zV2FPT0WU
DOKNHn6[FdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml;ITWM2OD1yLki0PEDPxE1?MWTTRW5ITVJ?
NCI-H2171M2jwcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX21WnpCUUN3ME2wMlg1QTZizszNNH\WfodUSU6JRWK=
NCI-SNU-5NYrFOVJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTBwOEW1O{DPxE1?NEjZR4RUSU6JRWK=
SK-N-DZMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1S1ZWlEPTB;MD64OVk1OyEQvF2=MVvTRW5ITVJ?
SNU-C2BMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTBwOE[4NFEh|ryPMlroV2FPT0WU
CP66-MELNFLEUIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYOwdVFJUUN3ME2wMlg4OTFizszNMYPTRW5ITVJ?
SN12CMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTBwOEi2N|ch|ryPNHr5S4VUSU6JRWK=
A172MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTYTWM2OD1yLki4Olk5KM7:TR?=MYLTRW5ITVJ?
NCI-H2347NHLOU3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnlNpVxUUN3ME2wMlg5PzV|IN88US=>NX35foY3W0GQR1XS
NCI-H2228MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPu[INKSzVyPUCuPFk{OzlizszNM1L6RXNCVkeHUh?=
SNU-387M2\OS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XqTGlEPTB;MD65NFI3PCEQvF2=NGTZV4RUSU6JRWK=
SK-MEL-24MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVP4SpQxUUN3ME2wMlkyOzR2IN88US=>MVLTRW5ITVJ?
MDA-MB-468M{DQVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTBwOUG3N{DPxE1?MW\TRW5ITVJ?
NCI-H1694MnvES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4W0XGlEPTB;MD65NVg4PiEQvF2=Ml75V2FPT0WU
CCF-STTG1NInEXFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzrcFBKSzVyPUCuPVI3OzdizszNMmSwV2FPT0WU
K052NF24dI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWn2R|NYUUN3ME2wMlk1ODR5IN88US=>M2\WTnNCVkeHUh?=
NCI-H446M1\HXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF\hNWZKSzVyPUCuPVUxOSEQvF2=M1e4[nNCVkeHUh?=
MFE-280NI\3dZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInMZYVKSzVyPUCuPVYzQTFizszNMofWV2FPT0WU
KU812NGXveoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\OTWM2OD1yLkm5N|g6KM7:TR?=M3vMOHNCVkeHUh?=
MDA-MB-361MnTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHhOVRKSzVyPUCuPVk4PzdizszNMWXTRW5ITVJ?
RajiNWm0VmFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlnxTWM2OD1zLkCyNlY4KM7:TR?=M3TJ[HNCVkeHUh?=
TE-6M4jxbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4X4dGlEPTB;MT6wN|U3PiEQvF2=MV\TRW5ITVJ?
CAL-148NIm4WYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmnGTWM2OD1zLkC0OFQ{KM7:TR?=MV7TRW5ITVJ?
NCI-H1963NUHndmF6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\BTWM2OD1zLkC0OVU{KM7:TR?=NHi0fYRUSU6JRWK=
SK-N-ASM2DYW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTLXVN5UUN3ME2xMlA1Pjh3IN88US=>NYjMPVB4W0GQR1XS
RERF-LC-MSNHz5So1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HzR2lEPTB;MT6wOlM1QSEQvF2=Mmf0V2FPT0WU
BENMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYLqT4MzUUN3ME2xMlA4OTN5IN88US=>MnvxV2FPT0WU
CAS-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{DhdWlEPTB;MT6wPVEzOyEQvF2=NVnjSWJ7W0GQR1XS
SW780M{XVemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2LuPWlEPTB;MT6wPVE5OSEQvF2=MXLTRW5ITVJ?
LU-65MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1PLdmlEPTB;MT6wPVQyKM7:TR?=M4PPU3NCVkeHUh?=
D-283MEDNXTsUXMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLN[G16UUN3ME2xMlEzOjd{IN88US=>NUH3VlJJW0GQR1XS
HCC2157MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE\XbYRKSzVyPUGuNVM3PDJizszNM{n0ZnNCVkeHUh?=
RCC10RGBMnPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXHGfVBuUUN3ME2xMlE1ODB4IN88US=>NGrzU3JUSU6JRWK=
PLC-PRF-5NUjQZolUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHe0V4xKSzVyPUGuNVUzOjlizszNNXvBcJBRW0GQR1XS
H4NYPrR2k{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rKSWlEPTB;MT6xOVQ{QSEQvF2=MVvTRW5ITVJ?
TURMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUPJR|UxRTFwMUW3OVIh|ryPNV62cYpXW0GQR1XS
NCI-H2141NWK5XJdtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLFTWM2OD1zLkG4PVQ3KM7:TR?=M1\oUnNCVkeHUh?=
PFSK-1MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTFwMkC1N|Ih|ryPMVnTRW5ITVJ?
SK-MEL-28MlrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2f5PWlEPTB;MT6yN|IzOSEQvF2=NWG3RpY1W0GQR1XS
SCC-9NGW1eIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2fPZWlEPTB;MT6yN|Y3PSEQvF2=NX3jXXgyW0GQR1XS
T47DNFX3W2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{mxXmlEPTB;MT6yN|Y6PiEQvF2=NYPGZ5NWW0GQR1XS
TCCSUPNGnFXJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULKS5VsUUN3ME2xMlI2ODJ7IN88US=>NELrUYpUSU6JRWK=
SU-DHL-1NEXLXopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\WOmlEPTB;MT6yOVEyQCEQvF2=MkL4V2FPT0WU
HL-60M3W4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTOTWM2OD1zLkK1OVg5KM7:TR?=Ml;MV2FPT0WU
NCI-H1436MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\SS2lEPTB;MT6yOlE1QSEQvF2=NYjhZW5wW0GQR1XS
DMS-114NWTGXm5NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXtTWM2OD1zLkK2OlMzKM7:TR?=MmfxV2FPT0WU
BOKUNFLnWmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvkPFg{UUN3ME2xMlI5ODl3IN88US=>Ml;GV2FPT0WU
MS-1MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYf2OJgzUUN3ME2xMlI6ODZ7IN88US=>MWPTRW5ITVJ?
NCI-H661MoHIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTFwM{C0O|gh|ryPMke2V2FPT0WU
HT-3NYW4Zlh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnrFTWM2OD1zLkOwOVI6KM7:TR?=NFrTcZFUSU6JRWK=
CAL-54NWXFe3QxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDlOXhKSzVyPUGuN|A4OjVizszNNHv2bZhUSU6JRWK=
SW1463MnHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTFwM{G4O|Ih|ryPMVvTRW5ITVJ?
COLO-668M{C0c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUS5PYV4UUN3ME2xMlM{ODV4IN88US=>MmnrV2FPT0WU
PANC-08-13MkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTFwM{O4NFMh|ryPNUjm[m9rW0GQR1XS
BB49-HNCMnrnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVrqSoV1UUN3ME2xMlM1ODFizszNMXnTRW5ITVJ?
M059JM4nUdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zpZWlEPTB;MT6zOVg{OiEQvF2=M1O1c3NCVkeHUh?=
NCCITM2\3RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rCTmlEPTB;MT6zO|k5QCEQvF2=NFraUXRUSU6JRWK=
LN-405MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2f3PWlEPTB;MT6zPVI3PCEQvF2=MXHTRW5ITVJ?
UMC-11NGS1clhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkfsTWM2OD1zLkO5PVk3KM7:TR?=M1nDdnNCVkeHUh?=
NB5MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfwbJlKSzVyPUGuOFEzOjdizszNMXLTRW5ITVJ?
TE-441-TM2XkOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTFwNEK4NVch|ryPMorGV2FPT0WU
ME-180MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV[0eZZ2UUN3ME2xMlQ1Ozl{IN88US=>NXG4V3hqW0GQR1XS
HCC70MoXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[zSmR5UUN3ME2xMlQ3ODl4IN88US=>M4XmdnNCVkeHUh?=
no-10M4fERmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTFwNE[xPFEh|ryPMUfTRW5ITVJ?
JEG-3NFjEN2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm[2TWM2OD1zLkWwNVMzKM7:TR?=NGTPPHdUSU6JRWK=
no-11NF;DRoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTFwNUC4PFIh|ryPM17VPXNCVkeHUh?=
CHP-126MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITJSpJKSzVyPUGuOVY3QTFizszNNF3ifYlUSU6JRWK=
EGI-1NWLKVlh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFWyVoJKSzVyPUGuOVgxOjVizszNMlTGV2FPT0WU
D-392MGMk\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\tTVNDUUN3ME2xMlU6PjNizszNM333UXNCVkeHUh?=
RT4NUi3fVBqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVzTO2pLUUN3ME2xMlU6PjN5IN88US=>M4HYdnNCVkeHUh?=
A204MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYX0[Jl2UUN3ME2xMlU6QDBzIN88US=>NI\se21USU6JRWK=
NCI-H1304NIDQS5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPzPWVZUUN3ME2xMlY{PTlzIN88US=>NF3yfoFUSU6JRWK=
BeckerNVnIZmhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M376UGlEPTB;MT62OFI1OSEQvF2=MXXTRW5ITVJ?
OE19MkXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\DXXBkUUN3ME2xMlY2PTF6IN88US=>NHHSZmNUSU6JRWK=
EKVXMnW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTFwNkW2NVgh|ryPNEHIUIJUSU6JRWK=
KLEM3nQdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTFwNkW3NVQh|ryPNHvZUWFUSU6JRWK=
K-562NYXYRoxYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnvETWM2OD1zLk[3NFM4KM7:TR?=NVX4flVyW0GQR1XS
MDA-MB-175-VIINHTCdVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTFwNki5PVch|ryPMknvV2FPT0WU
NCI-H716M3fZNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTFwNkmzNFQh|ryPNVLCNYt3W0GQR1XS
Caov-3NHXzNGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;CTWM2OD1zLk[5OFE{KM7:TR?=NFHpeZJUSU6JRWK=
HCC1187MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml2wTWM2OD1zLkewOVQ2KM7:TR?=MkK4V2FPT0WU
CAKI-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fNR2lEPTB;MT63NlI6OiEQvF2=MlziV2FPT0WU
MOLT-16NHzBNnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDDWY1LUUN3ME2xMlc{OzB5IN88US=>M3q1N3NCVkeHUh?=
PC-3M{TyT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTFwN{WwPEDPxE1?NGTES4xUSU6JRWK=
DV-90MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLYTWM2OD1zLke1OVg2KM7:TR?=M2\Md3NCVkeHUh?=
RXF393MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1e4UGlEPTB;MT63O|I6PCEQvF2=NWjwOIxKW0GQR1XS
SK-NEP-1M3\XVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3H2emlEPTB;MT64NlM{QSEQvF2=NF3I[oJUSU6JRWK=
HCC1419NE[xZnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTFwOEK2PVIh|ryPM1zHbnNCVkeHUh?=
BV-173MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFu3R4ZKSzVyPUGuPFI6QTVizszNMV3TRW5ITVJ?
MKN7NE\jUFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIm0fJdKSzVyPUGuPFkzOiEQvF2=NEflSmlUSU6JRWK=
LAN-6M4DPSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTFwOEm1OVMh|ryPNIjoVlZUSU6JRWK=
Mo-TNF;MPFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIn3dYtKSzVyPUGuPVAxOzlizszNM4f1[HNCVkeHUh?=
HCC1395Mk\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTJdFI5UUN3ME2xMlkzQDZ|IN88US=>M1\EUnNCVkeHUh?=
HC-1NVnQbldTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1G3ZmlEPTB;MT65N|Q4KM7:TR?=NW[yb2JqW0GQR1XS
HPAF-IIMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTFwOUS0NVgh|ryPM37IUHNCVkeHUh?=
CPC-NMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3XTXUyUUN3ME2xMlk5ODB{IN88US=>NH2yS3hUSU6JRWK=
MKN45MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPRS5MxUUN3ME2xMlk6OTF7IN88US=>NWPTeIl{W0GQR1XS
NCI-H1693M3zUWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXrPXdKSzVyPUKuNFA1OzNizszNNYXJ[3JuW0GQR1XS
SHP-77NU\RfZNkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{P6UmlEPTB;Mj6wNFU{OyEQvF2=NFvkUo9USU6JRWK=
NCI-H1522NF;TO2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTJwMEG3NlQh|ryPNYGzWXBYW0GQR1XS
SW1573MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHsTWM2OD1{LkCyNkDPxE1?Mk\QV2FPT0WU
DBTRG-05MGM1i4Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;0W5NKSzVyPUKuNFYxQDdizszNMUDTRW5ITVJ?
SCC-4NXTjZohpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnPb5NmUUN3ME2yMlE1OzFizszNNF\FV3FUSU6JRWK=
DMS-153NITMc2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XFS2lEPTB;Mj6xOlY3QCEQvF2=MkXBV2FPT0WU
MDA-MB-415NH;CeotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\QdpY3UUN3ME2yMlE4PTJizszNNFXYeXZUSU6JRWK=
NCI-H2126MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml20TWM2OD1{LkKyPFg5KM7:TR?=NUXLV3lXW0GQR1XS
MDA-MB-453NHHtWnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTJwMkOzNkDPxE1?MWLTRW5ITVJ?
U-87-MGMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTJwMki1PVIh|ryPNHHUd4ZUSU6JRWK=
LNCaP-Clone-FGCNVvqRmFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\oTWM2OD1{LkOwNVAzKM7:TR?=NV;0OI9{W0GQR1XS
NCI-H1581MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3S4PGlEPTB;Mj6zNlExPSEQvF2=NH7SR3lUSU6JRWK=
BC-3NG\vc2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWPJR|UxRTJwM{[1NFkh|ryPMkDLV2FPT0WU
HCC38NYTkfo57T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlfvTWM2OD1{LkO4OFQ4KM7:TR?=NUS4e3VVW0GQR1XS
HCC2218MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTJwNEC4NFkh|ryPM{D1cHNCVkeHUh?=
RO82-W-1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXaTWM2OD1{LkSxNlUh|ryPMV\TRW5ITVJ?
C2BBe1MnHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7EbWx2UUN3ME2yMlQyPTd6IN88US=>NHzITJBUSU6JRWK=
LAMA-84MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjIRpRmUUN3ME2yMlU4OzZ6IN88US=>M1mxfXNCVkeHUh?=
GMS-10NFPyPG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXrVGxKSzVyPUKuOVc3OTFizszNMWXTRW5ITVJ?
GCTNGH2ZpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnzjTWM2OD1{LkW4Olk1KM7:TR?=NWP1dHBiW0GQR1XS
SK-CO-1NGHleZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTJwNkG2OkDPxE1?M1\BXHNCVkeHUh?=
NCI-H526MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{L1OmlEPTB;Mj62N|Q2KM7:TR?=M4fEVHNCVkeHUh?=
SW1088NF73OHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{T3NmlEPTB;Mj63O|g{QSEQvF2=M2XXcHNCVkeHUh?=
HT55NXHOXnJGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV:0WIE3UUN3ME2yMlc5Pjl3IN88US=>NUewWnNXW0GQR1XS
NB10NE\DVmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTJwOEG3OFgh|ryPNIjqfVZUSU6JRWK=
UACC-893NH\oUINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTJwOEW3OFkh|ryPM12wdnNCVkeHUh?=
NCI-H1618MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLRTWM2OD1{Lki4NVU{KM7:TR?=Mm[0V2FPT0WU
NCI-H1092NI\VZXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PIUWlEPTB;Mz6wO|gyOiEQvF2=NVPS[5lwW0GQR1XS
SBC-1M1jjT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfxTWM2OD1|LkC4OVU{KM7:TR?=MXXTRW5ITVJ?
NCI-H1623MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\ydmlEPTB;Mz6wPVM1KM7:TR?=M2iy[3NCVkeHUh?=
SiHaMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV33[FlLUUN3ME2zMlEyQTd5IN88US=>NWDtWHh{W0GQR1XS
D-263MGMofsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3zWemlEPTB;Mz6xOFc5QCEQvF2=NEH0TpBUSU6JRWK=
NCI-H1573MmHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvh[4VKSzVyPUOuNVk3PDFizszNMUXTRW5ITVJ?
NCI-H82NGPFTm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHvmR4VKSzVyPUOuN|Q1OzlizszNNI\BVIJUSU6JRWK=
NCI-H2196M4HZT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXCO49{UUN3ME2zMlM2ODB6IN88US=>NXTOTHRmW0GQR1XS
MFM-223NVnjcVJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3W5cGlEPTB;Mz6zO|M2OSEQvF2=MoPZV2FPT0WU
COLO-678MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlu5TWM2OD1|LkO4NVg3KM7:TR?=NHvkTmdUSU6JRWK=
EW-3NYHJTHVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTNwNEC5OUDPxE1?M3fnVXNCVkeHUh?=
MHH-NB-11NWDKZ|NGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTNwNESwOlkh|ryPM3nNbHNCVkeHUh?=
EM-2MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\STWM2OD1|Lk[zPVgh|ryPNE\pR3VUSU6JRWK=
FTC-133NYrRWIpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEGwdHZKSzVyPUOuOlU1PThizszNMnP4V2FPT0WU
NCI-H209NIHYbZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PpPWlEPTB;Mz62O|Y2OyEQvF2=MmDyV2FPT0WU
TGBC24TKBMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGLFT2NKSzVyPUOuOlg{PTVizszNNX7Cd4l2W0GQR1XS
LC-1FNX;PSZlYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDBPY9sUUN3ME2zMlcyPzZ2IN88US=>MYDTRW5ITVJ?
C-4-IIMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;aeGlEPTB;Mz63OVY1OyEQvF2=M3rSPHNCVkeHUh?=
NCI-H1650NFzncpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2XZbmlEPTB;Mz63PFQ2PSEQvF2=MX;TRW5ITVJ?
JVM-2NYGwUG92T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLYTWM2OD1|LkmzOlM6KM7:TR?=M2W0T3NCVkeHUh?=
CaR-1MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHNTWM2OD1|Lkm3OlE4KM7:TR?=Mnf4V2FPT0WU
MDA-MB-134-VINHHFOplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHMTWM2OD12LkCyPVUzKM7:TR?=MmexV2FPT0WU
NCI-H719NYrld4xTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTRwMUWzPFgh|ryPM{XFPHNCVkeHUh?=
GOTONF7tUIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTwOJVlUUN3ME20MlI6PzB3IN88US=>MlL6V2FPT0WU
NCI-N87MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPSTWM2OD12LkO4PFIyKM7:TR?=NF3oRo9USU6JRWK=
NB6NFzKV2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HPRWlEPTB;ND60NlUxQSEQvF2=NUG3cYJ4W0GQR1XS
DSH1MmP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGW3R3ZKSzVyPUSuOFcyOTZizszNNWK3c2FIW0GQR1XS
BT-20MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTRwNEmwNFIh|ryPNIK1bINUSU6JRWK=
NCI-H1882NWTHd45MT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rNW2lEPTB;ND61NFU4KM7:TR?=NEnGb3FUSU6JRWK=
WM-115M4njZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn72TWM2OD12LkWwPFgyKM7:TR?=NH74VW9USU6JRWK=
SKG-IIIaM1\tbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzhR3N2UUN3ME20MlY4PzdizszNMXrTRW5ITVJ?
NCI-H69MoXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTRwN{CyO|Uh|ryPM17wUHNCVkeHUh?=
MSTO-211HNYi4dGhCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTRwOEO1OlUh|ryPNVn4VGFZW0GQR1XS
MewoMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTRwOU[zNVMh|ryPM3X2VnNCVkeHUh?=
GI-ME-NMnT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojvTWM2OD13LkCwOVA6KM7:TR?=NGLxcIJUSU6JRWK=
T98GMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXyVGVwUUN3ME21MlA3PTB6IN88US=>M3O2TXNCVkeHUh?=
ECC4NXvDeFJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4q2U2lEPTB;NT6wPVM4OiEQvF2=Mn\0V2FPT0WU
EW-11NVnCUGx2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTVwMUiwPVkh|ryPMmfzV2FPT0WU
COLO-800NWnheIhbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTFTWM2OD13LkG5N|Q6KM7:TR?=MX7TRW5ITVJ?
NCI-H1755NHXubG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1f0UWlEPTB;NT6yN|AzPyEQvF2=MonhV2FPT0WU
KMS-12-PEMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrhTWM2OD13LkO1NFg2KM7:TR?=M{PXcnNCVkeHUh?=
HCC1954NUPjdolpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjJS5JSUUN3ME21Mlg2QTdzIN88US=>NU\r[|RCW0GQR1XS
NCI-H187MoH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFG3fGxKSzVyPUWuPVI6QDlizszNNUD6ZY5SW0GQR1XS
LU-165MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTVwOUmwNFIh|ryPM{XGOXNCVkeHUh?=
YAPCNULKW4pET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULzW|JSUUN3ME21Mlk6ODZ6IN88US=>MYfTRW5ITVJ?
LU-139NVyxTFlGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXzTb2pvUUN3ME22MlA5OzZ6IN88US=>NYTzcnc{W0GQR1XS
D-502MGMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTZwM{KwOFch|ryPM3j5S3NCVkeHUh?=
IST-SL1NWDmT5d3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3QTWM2OD14LkWzPVQ5KM7:TR?=NWrSXVFYW0GQR1XS
DG-75MmPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLGTWM2OD14Lki4O|g3KM7:TR?=MkD0V2FPT0WU
NCI-H1155M3:4bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXqTWM2OD14Lkm1OVgyKM7:TR?=MmT0V2FPT0WU
EFE-184M1;NS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVHXVZJFUUN3ME23MlMyPjl3IN88US=>MW\TRW5ITVJ?
AsPC-1NEHxfXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITW[GtKSzVyPUeuOFg5ODdizszNNIftOm5USU6JRWK=
SW948M1nWe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;pTWM2OD15LkW4N|k2KM7:TR?=NXftfmVUW0GQR1XS
NCI-H524M3vXVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmnYTWM2OD17LkW4OlI5KM7:TR?=Mn3TV2FPT0WU
KOSC-2M2TSU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4XPbWlEPTB;OT62Nlg{PCEQvF2=M3zMVXNCVkeHUh?=
T-24MoHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnq1TWM2OD17Lkm0OFE2KM7:TR?=M3POcXNCVkeHUh?=
NCI-H748M1zLOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTFyLk[zPVch|ryPNY\nTXNmW0GQR1XS
NCI-H23NHP5e2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3z0VWlEPTB;MUCuOlQ1OiEQvF2=Mm\YV2FPT0WU
UACC-812MljHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXiUnBKSzVyPUGxMlcyPyEQvF2=NHnvbHdUSU6JRWK=
SCLC-21HMn7oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI\IfHlKSzVyPUGyMlE2PTFizszNNHfaOoJUSU6JRWK=
NCI-SNU-16M3Pse2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjpdIRUUUN3ME2xN{4yOjV6IN88US=>NX3WVFExW0GQR1XS
HD-MY-ZNH6zdWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTF2Lk[zOlMh|ryPMXrTRW5ITVJ?
SK-N-FIMnHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTF2Lki5NVIh|ryPNVzM[YlEW0GQR1XS
LB647-SCLCNEDBXI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3f1XWlEPTB;MUWuO|E6PSEQvF2=NU[yZVBYW0GQR1XS
NCI-H345Mn;1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGfD[WpKSzVyPUG3MlM1OyEQvF2=NIr4XXRUSU6JRWK=
NCI-H1563M1vaUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3zHfmlEPTB;MUiuO|YxOSEQvF2=MVLTRW5ITVJ?
RLNFTBfphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofjTWM2OD1{MT6yOlU3KM7:TR?=NUP5U4FVW0GQR1XS
KY821M2rWcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXHcVlvUUN3ME2yNk4xPTV|IN88US=>NVzFTlY2W0GQR1XS
JVM-3MnvhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTJ3LkC0NVMh|ryPNELVRpdUSU6JRWK=
NCI-H1793M4XO[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\6OWlEPTB;MkiuOVQ6QSEQvF2=M2XtVnNCVkeHUh?=
LU-134-AMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIOxWlFKSzVyPUOwMlIxOzdizszNMXfTRW5ITVJ?
NCI-H1395Mn;OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoXWTWM2OD1|Mj6yOFMyKM7:TR?=NEfaNYtUSU6JRWK=
NCI-H1993MmSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTN{LkiyNVgh|ryPMlHlV2FPT0WU
P31-FUJNEPiboNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTN|LkS4PVkh|ryPM3L0XXNCVkeHUh?=
LS-513MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXLJR|UxRTN3Lki4O|kh|ryPM1fV[HNCVkeHUh?=
SK-MEL-1MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPScYt1UUN3ME20NE4{PDl7IN88US=>NWrMW|dIW0GQR1XS
SW684NV;CVVl5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moe3TWM2OD12Mz65OlYyKM7:TR?=MoTNV2FPT0WU
COR-L88M4f5eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvFTWM2OD12ND6wOlY2KM7:TR?=M3zHTXNCVkeHUh?=
NCI-H889NFrHSm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NILPOlVKSzVyPUS1MlAxQDdizszNMWnTRW5ITVJ?
TALL-1MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYfvXnFvUUN3ME20Ok4yOTl7IN88US=>NF3W[GRUSU6JRWK=
KARPAS-299NGi3SVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjYXWNHUUN3ME20O{4yQTl|IN88US=>NVfoXIpuW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Obatoclax also exhibits high antitumor activity in SCID mice bearing human C33A cerivical carcinoma tumors at a dose of 0.5 mg/kg. [1]
Features Potential 1st-in-class small molecule antagonist of Bcl-2 designed to inhibit all relevant Bcl-2 family members, including Mcl-1.

Protocol(Only for Reference)

Kinase Assay: [1]

Bcl-2 Binding affinity calculation A predicted binding affinity for Obatoclax binding to BCL-2 is calculated using the SIE scoring function. [4] As a control in determining the reliability of the calculation, predicted binding affinities Ki) are calculated for a set of 12 small molecules with experimentally measured binding affinities to BCL-2.

Cell Assay: [2]

Cell lines Human MM cells (HMCLs), peripheral blood lymphocytes (PBLs), bone marrow stromal cells (BMSCs)
Concentrations ~10 μM
Incubation Time 48-72 hours
Method Obatoclax is dissolved in DMSO at a stock concentration of 5 mM. Cell viability is assayed by MTT. Human MM cells (HMCLs), peripheral blood lymphocytes (PBLs), bone marrow stromal cells (BMSCs) are seeded in 96-well plates at a density of 2 × 104 per well for HMCLs or 5~10 × 103 for PBLs. Various concentrations of Obatoclax are added to the cells, with or without IGF-1 (50 ng/mL) or IL-6 (10 ng/mL). Cells are incubated for 48-72 hours and cell viability is determined.

Animal Study: [1]

Animal Models Female BALB/c or CB17 SCID/SCID mice bearing SW480, C33A, PC3, and 4T1 cells are used.
Formulation Obatoclax (tartrate salt) is formulated in 9.6% polyethylene glycol 300, 0.4% polysorbate 20, and 5% dextrose; while for the 4T1 tumor model, Obatoclax is formulated at a concentration of 0.6 mg/mL in 9.48% polyethylene glycol, 0.38% polysorbate 20, 1.2 m
Dosages 0.0313, 0.25, 0.5 and 2 mg/kg
Administration Administered intravenously (tail vein) once a day

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Nguyen M, et al. Proc Natl Acad Sci, 2007, 104(49), 19512-191517.

[2] Trudel S, et al. Blood, 2009, 113(2), 299-305.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01563601 Withdrawn Extensive-stage Small Cell Lung Cancer Cephalon|Teva Pharmaceutical Industries August 2012 Phase 3
NCT01238146 Withdrawn Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymp  ...more Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Splenic Marginal Zone Lymphoma National Cancer Institute (NCI) October 2010 Phase 1|Phase 2
NCT00933985 Terminated Acute Leukemias of Ambiguous Lineage|Acute Undifferentiated Leukemia|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|  ...more Acute Leukemias of Ambiguous Lineage|Acute Undifferentiated Leukemia|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Small Intestine Lymphoma|Unspecified Childhood Solid Tumor, Protocol Specific National Cancer Institute (NCI) June 2009 Phase 1
NCT00918931 Terminated Leukemia|Systemic Mastocytosis M.D. Anderson Cancer Center|Gemin X June 2009 Phase 2
NCT00719901 Terminated Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma National Cancer Institute (NCI) July 2008 Phase 1|Phase 2

view more

Chemical Information

Download Obatoclax Mesylate (GX15-070) SDF
Molecular Weight (MW) 413.49
Formula

C20H19N3O.CH4O3S

CAS No. 803712-79-0
Storage 3 years -20℃powder
2 years -80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 83 mg/mL (200.73 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name (Z)-2-(5-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-4-methoxy-5H-pyrrol-2-yl)-1H-indole mesylate

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcl-2 Products

  • A-1210477

    A-1210477 is a potent and selective MCL-1 inhibitor with Ki and IC50 of 0.454 nM and 26.2 nM, respectively, >100-fold selectivity over other Bcl-2 family members.

  • MI-773 (SAR405838)

    MI-773 (SAR405838) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1.

  • ABT-263 (Navitoclax)

    ABT-263 (Navitoclax) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM and ≤1 nM in cell-free assays, but binds more weakly to Mcl-1 and A1. Phase 2.

  • Venetoclax (ABT-199, GDC-0199)

    Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays, >4800-fold more selective versus Bcl-xL and Bcl-w, and no activity to Mcl-1. Phase 3.

    Features:Re-engineered version of ABT-263 (Navitoclax).

  • ABT-737

    ABT-737 is a BH3 mimetic inhibitor of Bcl-xL, Bcl-2 and Bcl-w with EC50 of 78.7 nM, 30.3 nM and 197.8 nM in cell-free assays, respectively; no inhibition observed against Mcl-1, Bcl-B or Bfl-1. Phase 2.

  • UMI-77

    UMI-77 is a selective Mcl-1 inhibitor with Ki of 490 nM, showing selectivity over other members of Bcl-2 family.

  • TW-37

    TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM in cell-free assays, respectively.

  • Sabutoclax

    Sabutoclax(BI-97C1) is a pan-Bcl-2 inhibitor, including Bcl-xL, Bcl-2, Mcl-1 and Bfl-1 with IC50 of 0.31 μM, 0.32 μM, 0.20 μM and 0.62 μM, respectively.

  • AT101

    AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32 μM, 0.48 μM and 0.18 μM in cell-free assays; does not inhibit BIR3 domain and BID. Phase 2.

Recently Viewed Items

Tags: buy Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) supplier | purchase Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) cost | Obatoclax Mesylate (GX15-070) manufacturer | order Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us